乳腺癌的新辅助治疗

所属专题：文献；

述评

乳腺癌的新辅助治疗

杨红健¹

Hong-jian YANG¹

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

杨红健. 乳腺癌的新辅助治疗[J]. 中华普通外科学文献(电子版), 2013, 07(04): 251-254.

Hong-jian YANG. Neoadjuvant therapy of breast cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(04): 251-254.

1	卫生部医政司. 乳腺癌诊疗规范（2011版）, 2011-06-23.
2	中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2011版).中国癌症杂志, 2011, 21(5): 367-417.
3	Kaufmann M, von Minckwitz G, Mamounas EP, et al. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol, 2012, 19(5): 1508-1516.
4	Berruti A, Generali D, Kaufmann M, et al. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). J Natl Cancer Inst Monogr, 2011, 7(43): 147-151.
5	National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Breast Cancer Version 3. 2012.
6	Gabriel H. Neoadjuvant Systemic Therapy: Promising Experimental Model, or Improved Standard of Care? 35th Annual SABCS, Boston, 2012.
7	Mohammadianpanah M, Ashouri Y, Hoseini S, et al. The efficacy and safety of neoadjuvant chemotherapy+/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial. Breast Cancer Res Treat, 2012, 132(3): 853-861.

No related articles found!

阅读次数

全文

摘要